Skip to main content
LIFE

Feops

Accelerating time to market, improving clinical outcome in structural heart interventions

IF WE PREDICT THE OUTCOME OF TRANSCATHETER STRUCTURAL HEART INTERVENTIONS, CAN WE ACCELERATE TIME TO MARKET AND IMPROVE CLINICAL OUTCOME?

Heart valve diseases are on the rise, as is the use of minimally invasive procedures to treat them. Long development cycles in MedTech makes the innovation of new, minimally invasive structural heart devices resource-intensive and challenging.

Modeling and simulation development and implantation of transcatheter structural heart devices

FEops HEARTguide™ technology uses advanced computational modeling and simulation to provide valve manufacturers and physicians with pre-operative insights into the interaction between patient anatomy and heart valve implants.

The first solution of its kind, FEops HEARTguide™ surpasses basic anatomical measurement, generating accurate predictions of how devices will interact with each unique patient. Our end-to-end solution adds value to optimize and accelerate every step in the structural heart product life cycle, helping manufacturers accelerate time to market and bringing physicians insights that contribute to better patient outcomes.

We help manufacturers accelerate the entire product life cycle and improve clinical outcome for structural heart interventions

FEops HEARTguide™  accelerates R&D processes, and product approval cycles, improves patient selection in clinical trials, and yields better clinical outcomes – benefiting device manufacturers, physicians and patients.

schema

 

BREAKTHROUGH IDEA

  • Create better implants faster

The proprietary predictive simulation technology that drives the FEops HEARTguide™ suite gives device manufacturers tremendous power to accelerate the development of novel minimally invasive structural heart implants. Introduce virtual patients or digital twins into your workflows before making physical prototypes to gain time, cut costs, and test in clinically relevant contexts.

  • Accelerate clinical trials

By improving patient selection and optimally preparing physicians for procedures through detailed predictive simulations, FEops HEARTguide™ can accelerate clinical trials and potentially contribute to better patient outcomes.

  • Launch products faster

Make it intuitive for physicians to adopt and endorse novel structural heart devices with FEops HEARTguide™. Inspire confidence and accelerate the learning curve by providing physicians with predictive 3D images that demonstrate how the device will interact with the unique anatomy of each patient – without putting patients at risk.

  • Bring patients better structural heart outcomes

In going beyond anatomical measurement, only FEops HEARTguide™ provides detailed preoperative insights into the interaction between the implant and the patient’s anatomy. This helps physicians determine optimal implant size and positioning.

 

BENEFITS TO USE THE 3DEXPERIENCE PLATFORM ON THE CLOUD

  • On-demand, cloud-based software and hardware facilities that will be essential for scalability and streamlined delivery of FEops HEARTguide™
  • 3D multiphysics simulation for the most accurate and personalized predictive insights into patients’ device-heart interactions
  • The potential to incorporate data science and machine learning into FEops HEARTguide™ processes thereby significantly reducing turnaround times

Meet the team

  • Nico Uwents
    Nico Uwents
    Director of business development
  • Christian  Vincent
    Christian Vincent
    Director of therapy development
  • Matthieu  De Beule
    Matthieu De Beule
    CEO, co-founder and member of the board of directors
  • Isabelle  Decroos
    Isabelle Decroos
    CFO
  • Peter  Mortier
    Peter Mortier
    CTO, co-founder and member of the board of directors

Similar projects

Submit your project

Do you think your project is the next big thing?
Join the team !

Submit your project